LabCorp is Scheduled to Speak at RBC Capital Markets' Healthcare Conference

BURLINGTON, N.C., Feb 23, 2010 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that William B. (Brad) Hayes, Executive Vice President and Chief Financial Officer, is scheduled to speak at the RBC Capital Markets' Healthcare Conference in New

LabCorp Announces New Holder of the Noncontrolling Interest in the Company's Ontario, Canada Joint Venture

BURLINGTON, N.C., Feb 17, 2010 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) announced today that on February 8, 2010 it completed a transaction to acquire the partnership units from the holder of the noncontrolling interest in the Company's Ontario, Canada

Laboratory Corporation of America(R) Holdings Announces 2009 Fourth Quarter and Full Year Results

Revenue Growth Drives Adjusted EPS of $1.16 and Operating Cash Flow of $224.7 Million BURLINGTON, N.C., Feb 11, 2010 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced results for the quarter and year ended December 31, 2009.

LabCorp is Scheduled to Present at the Jefferies 2010 Global Healthcare Services Conference

BURLINGTON, N.C., Jan 19, 2010 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) today announced that David P. King, Chairman and Chief Executive Officer, is scheduled to speak at the Jefferies 2010 Global Healthcare Services Conference in New York, NY.

Conversion Right Triggered for LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C., Jan 05, 2010 (BUSINESS WIRE) -- Laboratory Corporation of America Holdings (LabCorp) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below. The Zero Coupon Notes are convertible into cash and

LabCorp is Scheduled to Present at the 28th Annual J.P. Morgan Healthcare Conference

BURLINGTON, N.C., Jan 05, 2010 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) today announced that David P. King, Chairman and Chief Executive Officer, is scheduled to speak at the 28th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

LabCorp Receives Notification from the Holders of the Minority Interest in the Company's Ontario, Canada Joint Venture

BURLINGTON, N.C., Dec 15, 2009 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today that it has received notification from the holders of the minority interest in the Company's Ontario, Canada joint venture, that they intend to put their remaining

LabCorp is Scheduled to Attend Deutsche Bank's 3rd Annual MedTools Investor Summit

BURLINGTON, N.C. --(BUSINESS WIRE)--Dec. 3, 2009-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE:LH) today announced that David P. King , Chairman and Chief Executive Officer, is scheduled to attend Deutsche Bank’s 3rd Annual MedTools Investor Summit in Boston, MA.

LabCorp is Scheduled to Present at the 21st Annual Piper Jaffray Health Care Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Nov. 23, 2009-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced that David P. King , Chairman and Chief Executive Officer, is scheduled to speak at the 21 st Annual Piper Jaffray Health Care Conference in New York City , NY.

LabCorp is Scheduled to Present at the Credit Suisse 18th Annual Healthcare Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Nov. 6, 2009-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced that William B. (Brad) Hayes , Executive Vice President and Chief Financial Officer, is scheduled to speak at the Credit Suisse 18 th Annual Healthcare Conference